Relief Therapeutics Holding SA (RLFB)

0.0293
+0.0009(+3.17%)
  • Volume:
    7,847,987
  • Bid/Ask:
    0.0280/0.0293
  • Day's Range:
    0.0268 - 0.0293
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH0100191136
  • S/N:10019113

RLFB Overview

Prev. Close
0.0284
Day's Range
0.0268-0.0293
Revenue
3.32M
Open
0.028
52 wk Range
0.0223-0.262
EPS
-0.01
Volume
7,847,987
Market Cap
115.26M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
10,225,916
P/E Ratio
-
Beta
-
1-Year Change
-85.91%
Shares Outstanding
4,116,467,260
Next Earnings Date
-
What is your sentiment on Relief Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Relief Therapeutics Holding SA Company Profile

Relief Therapeutics Holding SA Company Profile

Employees
24

RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell